Literature DB >> 28096924

Scrotal recurrence of germ cell tumour in a non-violated scrotum.

Jenny Li1, Nicholas Power2.   

Abstract

Testicular cancer is the most common cancer diagnosis in males aged 15-30 years. For over a century, radical inguinal orchiectomy has been the standard of care for initial treatment of testicular cancer. This approach is preferred over trans-scrotal interventions, in an effort to avoid tumour seeding, spermatic cord invasion, and disturbance to lymphatic drainage. Scrotal violation is defined as any trans-scrotal intervention that may impact spread of disease in testicular cancer, including scrotal orchiectomy, fine-needle aspiration, and testicular biopsy. Studies have shown statistically significant differences in local recurrence rates between patients who undergo the standard inguinal surgical approach and cases with scrotal violation. Over 95% of testicular cancers are curative, often with surgery alone. Recurrence of disease is divided into two categories: local and distant sites. Local recurrence of testicular cancer involves the scrotal and inguinal regions, including superficial inguinal lymph nodes. More commonly, local recurrence is seen in cases of testicular cancer with scrotal violation. We describe a case of local recurrence of testicular cancer in a non-violated scrotum, a finding that has not been previously reported in the literature.

Entities:  

Year:  2016        PMID: 28096924      PMCID: PMC5234406          DOI: 10.5489/cuaj.3505

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  11 in total

Review 1.  Regular review: Managing testicular cancer.

Authors:  D Dearnaley; R Huddart; A Horwich
Journal:  BMJ       Date:  2001-06-30

Review 2.  Guidelines on the management of adult testicular cancer.

Authors: 
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

3.  Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.

Authors:  Philippe E Spiess; Wassim Kassouf; Gordon A Brown; Ashish M Kamat; Ping Liu; Jose A Gomez; Shi-Ming Tu; Nizar M Tannir; Louis L Pisters
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

4.  Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?

Authors:  F T Aki; C Y Bilen; M I Tekin; H Ozen
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

5.  The malignant potential of postchemotherapy residual mature teratoma for disseminated nonseminomatous testicular tumors.

Authors:  O Nativ; I Shajrawi; I Leibovitch; B Moskovitz
Journal:  Eur Urol       Date:  1994       Impact factor: 20.096

6.  The growing teratoma syndrome.

Authors:  C J Logothetis; M L Samuels; A Trindade; D E Johnson
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

7.  Primary pure teratoma of the testis.

Authors:  P D Simmonds; A H Lee; J M Theaker; K Tung; C J Smart; G M Mead
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

8.  A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?

Authors:  C C Capelouto; P E Clark; B J Ransil; K R Loughlin
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

9.  The growing teratoma syndrome secondary to immature teratoma of the ovary.

Authors:  Tsutomu Inaoka; Koji Takahashi; Tomonori Yamada; Naoyuki Miyokawa; Yoshihiko Tokusashi; Makoto Yoshida; Masaya Sugimoto; Kazutoshi Miyamoto; Tamio Aburano
Journal:  Eur Radiol       Date:  2002-10-15       Impact factor: 5.315

10.  The growing teratoma syndrome: Current review of the literature.

Authors:  Vladislav Gorbatiy; Philippe E Spiess; Louis L Pisters
Journal:  Indian J Urol       Date:  2009-04
View more
  1 in total

1.  Case of testicular nonseminomatous germ cell tumor cancer soft tissue seeding after inguinal orchiectomy.

Authors:  Jeffrey Vehawn; Mouneeb Choudry; Jonathon Mahlow; Jayant Agarwal; Christopher Dechet; Alejandro Sanchez
Journal:  Urol Case Rep       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.